key: cord-0890413-57wmksnh
authors: Faust, J.; Du, C.; Mayes, K.; Li, S.-X.; Lin, Z.; Barnett, M. L.; Krumholz, H. M.
title: Mortality from injury, overdose and suicide during the 2020 COVID-19 pandemic, March-July, 2020
date: 2021-02-16
journal: nan
DOI: 10.1101/2021.02.13.21251682
sha: 4337823c95184ca5676448eaa514e8d359cc628b
doc_id: 890413
cord_uid: 57wmksnh

Introduction The COVID-19 pandemic has been associated with substantial rates of all-cause excess mortality. The contribution of external causes of death to excess mortality including drug overdose, homicide, suicide, and unintentional injuries during the initial outbreak in the United States is less well documented. Methods Using public data published by the National Center for Health Statistics on February 10, 2021, we measured monthly excess mortality (the gap between observed and expected deaths) from five external causes using national-level data published by National Center for Health Statistics; assault (homicide); intentional self-harm (suicide); accidents (unintentional injuries); and motor vehicle accidents. We used seasonal autoregressive integrated moving average (sARIMA) models developed with cause-specific monthly mortality counts and US population data from 2015-2019 and estimated the contribution of individual cause-specific mortality to all-cause excess mortality from March-July 2020. Results From March-July, 2020, 212,825 (95% CI 136,236-290,776) all-cause excess deaths occurred in the US). There were 8,540 excess drug overdoses (all intents) (95% CI 5,106 to 11,975), accounting for 4% of all excess mortality; 1,455 excess homicide deaths (95% CI 708 to 2202, accounting for 0.7% of excess mortality; 5,492 excess deaths due to unintentional accidents occurred (95% CI 85 to 10,899, accounting for 2.6% of excess mortality. Though a non-significantly 135 (95% CI -1361 to 1,630) more MVA deaths were recorded during the study period, a significant decrease in April (525; 95% CI -817 to -233) and significant increases in June-July (965; 95% CI 348 to 1,587) were observed. Suicide deaths were statistically lower than projected by 2,067 (95% CI 941-3,193 fewer deaths). Meaning Excess deaths from drug overdoses, homicide, and addicents occurred during the pandemic but represented a small fraction of all-cause excess mortality. The excess external causes of death, however, still represent thousands of lives lost. Notably, deaths from suicide were lower than expected and therefore did not contribute to excess mortality.

The COVID-19 pandemic has been associated with substantial rates of all-cause excess mortality. The contribution of external causes of death to excess mortality including drug overdose, homicide, suicide, and unintentional injuries during the initial outbreak in the United States is less well documented.

Using public data published by the National Center for Health Statistics on February 10, 2021, we measured monthly excess mortality (the gap between observed and expected deaths) from five external causes using national-level data published by National Center for Health Statistics; assault (homicide); intentional self-harm (suicide); accidents (unintentional injuries); and motor vehicle accidents. We used seasonal autoregressive integrated moving average (sARIMA) models developed with causespecific monthly mortality counts and US population data from 2015-2019 and estimated the contribution of individual cause-specific mortality to all-cause excess mortality from March-July 2020.

From March-July, 2020, 212,825 (95% CI 136,236-290,776) all-cause excess deaths occurred in the US). There were 8,540 excess drug overdoses (all intents) (95% CI 5,106 to 11,975), accounting for 4% of all excess mortality; 1,455 excess homicide deaths (95% CI 708 to 2202, accounting for 0.7% of excess mortality; 5,492 excess . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint deaths due to unintentional accidents occurred (95% CI 85 to 10,899, accounting for 2.6% of excess mortality. Though a non-significantly 135 (95% CI -1361 to 1,630) more MVA deaths were recorded during the study period, a significant decrease in April (525; 95% CI -817 to -233) and significant increases in June-July (965; 95% CI 348 to 1,587) were observed. Suicide deaths were statistically lower than projected by 2,067 (95% CI 941-3,193 fewer deaths).

Excess deaths from drug overdoses, homicide, and addicents occurred during the pandemic but represented a small fraction of all-cause excess mortality. The excess external causes of death, however, still represent thousands of lives lost. Notably, deaths from suicide were lower than expected and therefore did not contribute to excess mortality.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 16, 2021.

All-cause excess mortality has been closely tracked during the COVID-19 pandemic.

However, the contribution of external causes of death during the initial months of the US outbreak is incompletely understood. 1-3 We analyzed monthly trends in drug overdose deaths, homicide, suicide, unintentional injuries, and motor vehicle accidents (MVAs) from 2015-2020, focusing on the first five months of the COVID-19 outbreak.

We measured monthly excess mortality (the gap between observed and expected deaths) from five external causes using national-level data published by National To forecast all-cause and cause-specific expected monthly deaths from March-July, 2020, we used seasonal autoregressive integrated moving average (sARIMA) models developed with cause-specific monthly mortality counts and US population data from . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint 2015-2019. We used the Akaike information criterion to select the best models. We plotted observed and expected deaths monthly with 95% CI estimated from sARIMA models. We estimated the contribution of individual cause-specific mortality to allcause excess mortality by dividing cause-specific mortality by total all-cause excess mortality from March-July 2020.

This study used publicly available data and was not subject to institutional review approval and adhered to STROBE guidelines. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint

Using provisional mortality data, we find that excess deaths from external causes occurred during the pandemic but represented a small fraction of all-cause excess mortality. The excess external causes of death, however, still represent thousands of lives lost exceeding pre-pandemic trends. Notably, deaths from suicide were lower than expected and therefore did not contribute to excess mortality.

Explanations for these excess external deaths are uncertain. Drug overdoses and homicides may be related to economic stress. Pandemic-associated changes in access to substance use disorder treatments could be exacerbating mortality from overdoses. 6 Decreases in MVA deaths in April coincided with less traffic, despite increases in drivers testing positive for drugs and alcohol and lower seatbelt use. 3

Increases in MVA deaths in June-July occurred as traffic increased (though still below 2019 levels), likely reflecting higher-risk behaviors. 3 A limitation of this study is that all 2020 data published by NCHS are considered preliminary. However, substantial changes to March-July 2020 data are unlikely.

The increases in external causes of death may have been preventable. These findings suggest the need for public health strategies, both now and in future outbreaks, to include attention on these and other socio-behavioral risks. These data suggest that enhanced safety measures may prove beneficial, not just during stay-at-home periods but during subsequent re-opening phases as well.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint

Dr. Faust had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. 

The solid black line indicates raw cause-specific death counts from January 2015-July 2020; the dashed green line represents the point estimate for cause-specific expected deaths from March-July 2020 using the seasonal adjusted model; the gray shaded area represents projected range (95% CI) of cause-specific deaths expected to occur during March-July 2020 using the seasonal adjusted model. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint 1A:

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint 1C.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint 1E.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 16, 2021. ; https://doi.org/10.1101/2021.02.13.21251682 doi: medRxiv preprint

Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic

Federal Bureau of Investigations. Overview of Preliminary Uniform Crime Report

Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic